A Trial Comparing the Efficacy and Safety of Liraglutide 1.8 mg/Day to Liraglutide 0.9 mg/Day in Japanese Subjects With Type 2 Diabetes Mellitus.

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2015
This trial is conducted in Asia. The aim of the trial is to compare the efficacy and safety of liraglutide 1.8 mg/day to liraglutide 0.9 mg/day in Japanese subjects with type 2 diabetes mellitus.
Epistemonikos ID: a5e11cc8c37e4189f8b4ac494b7732c9d98e90fe
First added on: May 12, 2024